Adenosine receptor activation reagent and the uses of thereof
AssigneeZhejiang Subtropical Crops Research Institute
InventorsYiqiu Chai, Bichun Zhu, Xiuxiu Peng, Yiwei Jin
Life of this patent
Estimating the term…
Abstract
The present invention relates to application of N(6)-(2-hydroxyethyl)-adenosine (HEA) and its derivatives as an adenosine A1 receptor agonist in preparation of drug or food, the HEA and its derivatives are used in treatment of diseases relating to adenosine receptor regulator, such as insomnia, pain, convulsion, apoplexia, Parkinson's disease, opioid drug addiction and kidney ischemia reperfusion injury etc. The present invention provides a new method for treatment of the diseases relating to nervous system and kidney.
Claims3
A method for treating a condition comprising administering N(6)-(2-hydroxyethyl)-adenosine (HEA) to a subject, wherein the condition is convulsion, pain, apoplexia, Parkinson's disease, or opioid drug addiction receptor;
- said HEA is administered in the amount of 10-15 mg/kg of subject body weight and treats the condition via the adenosine A1 receptor.
Dependencies are inferred from the claim text.